MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • MDS Virtual Congress 2021

    Hemichorea and contralateral hemidystonia after acute stroke

    P. Lorenzo Barreto, R. Sainz Amo, F. Pérez Trapote, A. Sáez Marín, E. Stiauren Fernández, JC. Martínez Castrillo, S. García Madrona (Madrid, Spain)

    Objective: To describe an unusual presentation of poststroke movement disorders. Background: Movement disorders occur uncommonly in association with stroke (1%), despite the frequent involvement of…
  • MDS Virtual Congress 2021

    A phase IV, randomized, double-blind cross-over study comparing the clinical safety, efficacy and duration of abobotulinumtoxinA with onabotulinumtoxinA in adults with upper-limb spasticity: The DIRECTION study

    A. Esquenazi, Z. Ayyoub, M. Verduzco-Gutierrez, P. Maisonobe, J. Otto, A. Patel (Elkins Park, USA)

    Objective: To evaluate the safety and efficacy of abobotulinumtoxinA in comparison to onabotulinumtoxinA when used at optimized doses in approved muscles common to both products’…
  • MDS Virtual Congress 2021

    Impacts of Tardive Dyskinesia (TD) Symptoms on Patients: Analysis of a TD-Specific Patient-Reported Outcome

    D. Stull, M. Bron, S. Bean, B. Williams, R. Farber, E. Franey, C. Yonan, R. Dhanda (New York, USA)

    Objective: To understand the impact of tardive dyskinesia (TD) symptoms on patients, confirm the appropriateness of the Tardive Dyskinesia Impact Scale (TDIS) as a patient-reported…
  • MDS Virtual Congress 2021

    Efficacy and safety of Botulinum toxin (BoNT) in lingual dystonia

    D. Nene, S. Cresswell (Vancouver, Canada)

    Objective: To evaluate the current evidence on the efficacy and safety of BoNT in treating lingual dystonia. Background: Lingual dystonia is a rare yet debilitating…
  • MDS Virtual Congress 2021

    Classifying pain in dystonia: a way to improve pain outcome measure in dystonia.

    C. Listik, E. Listik, J. Lapa, G. Santos, F. Do Vale, R. Cury, M. Teixeira, J. Limongi, H. Ferraz, E. Barbosa, D. de Andrade (São Paulo, Brazil)

    Objective: To improve the classification system for pain in dystonia. Background: Pain is a frequent and incapacitating non-motor symptom in dystonia. Evidence indicates that pain…
  • MDS Virtual Congress 2021

    Characterizing the temporal discrimination threshold in musician’s dystonia

    F. Borngräber, M. Hoffmann, T. Paulus, J. Junker, T. Bäumer, E. Altenmüller, A. Kühn, A. Schmidt (Berlin, Germany)

    Objective: To compare the temporal discrimination threshold (TDT) between musician's dystonia (MD) patients, healthy musicians and non-musician controls. Background: MD is a focal, task specific…
  • MDS Virtual Congress 2021

    The online MDS educational resources helped young neurologists maintain their training during the Covid-19 pandemic

    S. El-Jaafary, M. Fabbri, T. de Lariestra, M. Matarazzo, B. Bergmans, M. Carecchio, R. Rajan, N. Vijiaratnam, H. Tibar, B. Bloem (Cairo, Egypt)

    Objective: To analyse the impact of the COVID-19 pandemic on the young MDS members assessing their satisfaction with the MDS virtual educational tools. Background: The…
  • MDS Virtual Congress 2021

    Optimizing an Electronic Health Records (EHR)-based Algorithm for Parkinson’s Disease Case Ascertainment

    A. Duarte Folle, L. Uhr, F. Agosta, T. Chang, C. Baddley, B. Ritz, C. Tanner, A. Wu, A. Wilson (Los Angeles, USA)

    Objective: To develop an EHR-based algorithm to classify patients with PD into three levels of diagnostic certainty. Background: EHRs can be a rich source of…
  • MDS Virtual Congress 2021

    Emerging parkinsonism in the PREDICT-PD cohort after 6-years of follow-up

    C. Simonet, A. Gill, J. Bestwick, A. Lees, G. Giovannoni, A. Schrag, A. Noyce (London, United Kingdom)

    Objective: To determine how motor features emerge over time in individuals estimated to be at higher risk of Parkinson’s disease (PD), compared with lower risk…
  • MDS Virtual Congress 2021

    Acute functional movement disorder in a Lupus patient

    D. Rebolledo, J. Diestel, I. Reyes (Mexico City, Mexico)

    Objective: Movement disorders (MD) in autoimmune diseases are uncommon. However, the initial presentation required that the clinicians characterize the clinical phenomenology. Rheumatological patients' complexity required…
  • « Previous Page
  • 1
  • …
  • 39
  • 40
  • 41
  • 42
  • 43
  • …
  • 132
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley